How breast cancer recurrences are found – a real-world, prospective cohort study

References

• Rojas MPMP, Telaro E, Moschetti I, et al. Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev. 2000;(4):CD001768.
   Google Scholar
• Cruickshank S, Barber M. Breast cancer follow-up after a primary diagnosis: a confused picture. Breast. 2019;46:97–100.
   PubMedGoogle Scholar
• Cardoso F, Kyriakides S, Ohno S, et al.; ESMO Guidelines Committee. Electronic address: [email protected]. Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(8):1194–1220.
   PubMed Web of Science ®Google Scholar
• Dewar JA, Kerr GR. Value of routine follow up of women treated for early carcinoma of the breast. Br Med J. 1985;291(6507):1464–1467.
   PubMedGoogle Scholar
• Louie RJ, Tonneson JE, Gowarty M, et al. Complete blood counts, liver function tests, and chest x-rays as routine screening in early-stage breast cancer: value added or just cost? Breast Cancer Res Treat. 2015;154(1):99–103.
   PubMedGoogle Scholar
• Loong S, Wilkins M, Bliss JM, et al. The effectiveness of the routine clinic visit in the follow-up of breast cancer patients: Analysis of a defined patient cohort. Clin Oncol (R Coll Radiol). 1998;10(2):103–106.
   PubMedGoogle Scholar
• Kokko R, Hakama M, Holli K. Follow-up cost of breast cancer patients with localized disease after primary treatment: a randomized trial. Breast Cancer Res Treat. 2005;93(3):255–260.
   PubMedGoogle Scholar
• Lu WL, Jansen L, Post WJ, et al. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat. 2009;114(3):403–412.
   PubMed Web of Science ®Google Scholar
• Karihtala P, Mantyniemi A, Kang SW, et al. Peroxiredoxins in breast carcinoma. Clin Cancer Res. 2003;9(9):3418–3424.
   PubMed Web of Science ®Google Scholar
• Isola J, Tanner M, Forsyth A, et al. Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization. Clin Cancer Res. 2004;10(14):4793–4798.
   PubMed Web of Science ®Google Scholar
• Holli K, Hakama M. Effectiveness of routine and spontaneous follow-up visits for breast cancer. Eur J Cancer Clin Oncol. 1989;25(2):251–254.
   PubMedGoogle Scholar
• de Bock GH, Bonnema J, van der Hage J, et al. Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a Meta-analysis and systematic review. J Clin Oncol. 2004;22(19):4010–4018.
   PubMedGoogle Scholar
• Pandya KJ, McFadden ET, Kalish LA, et al. A retrospective study of earliest indicators of recurrence in patients on Eastern cooperative oncology group adjuvant chemotherapy trials for breast cancer. A preliminary report. Cancer. 1985;55(1):202–205.
   PubMedGoogle Scholar
• Ogawa Y, Ikeda K, Izumi T, et al. First indicators of relapse in breast cancer: evaluation of the follow-up program at our hospital. Int J Clin Oncol. 2013;18(3):447–453.
   PubMedGoogle Scholar
• Pivot X, Asmar L, Hortobagyi GN, et al. A retrospective study of first indicators of breast cancer recurrence. Oncology. 2000;58(3):185–190.
   PubMedGoogle Scholar
• Viot J, Bachour M, Meurisse A, et al. Follow-up of patients with localized breast cancer and first indicators of advanced breast cancer recurrence: a retrospective study. Breast. 2017;34:53–57.
   PubMedGoogle Scholar
• Schapira DV. Breast cancer surveillance-a cost-effective strategy. Breast Cancer Res Treat. 1993;25(2):107–111.
   PubMedGoogle Scholar
• Montgomery DA, Krupa K, Cooke TG. Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer. 2007;97(12):1632–1641.
   PubMed Web of Science ®Google Scholar
• Itani N, Grogan N, Mott S, et al. Metastatic presentations of previously treated early-stage breast cancer patients and association with survival. Clin Breast Cancer. 2020;20(3):209–214.
   PubMed Web of Science ®Google Scholar
• Perrone MA, Musolino A, Michiara M, et al. Early detection of recurrences in the follow-up of primary breast cancer in an asymptomatic or symptomatic phase. Tumori. 2004;90(3):276–279.
   PubMedGoogle Scholar
• Tomin R, Donegan WL. Screening for recurrent breast cancer-its effectiveness and prognostic value. J Clin Oncol. 1987;5(1):62–67.
   PubMedGoogle Scholar
• Cardoso F, Senkus E, Costa A, et al. 4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4)†. Ann Oncol. 2018;29(8):1634–1657.
   PubMed Web of Science ®Google Scholar
• Cheung WY, Neville BA, Earle CC. Associations among cancer survivorship discussions, patient and physician expectations, and receipt of follow-up care. J Clin Oncol. 2010;28(15):2577–2583.
   PubMed Web of Science ®Google Scholar
• Takala L, Kuusinen TE, Skyttä T, et al. Electronic patient-reported outcomes during breast cancer adjuvant radiotherapy. Clin Breast Cancer. 2021;21(3):e252–e270.
   PubMedGoogle Scholar
• Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–565.
   PubMed Web of Science ®Google Scholar